about
Zika virus in semen of a patient returning from a non-epidemic areaHepatitis E PathogenesisChronic hepatitis e virus infection and treatmentUnique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.Multicenter Quality Control for the Detection of Hepatitis C Virus RNA in Seminal Plasma SpecimensNew Natural Intergenotypic (2/5) Recombinant of Hepatitis C VirusMulticenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load DeterminationZIKA virus reveals broad tissue and cell tropism during the first trimester of pregnancyX4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHIMinor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failureA Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingZika Virus Infection and Prolonged Viremia in Whole-Blood SpecimensZika virus: high infectious viral load in semen, a new sexually transmitted pathogen?Intra-host viral variability in children clinically infected with H1N1 (2009) pandemic influenza.Hepatitis C virus infection in nephrology patientsIntermittent antiretroviral therapy in patients with controlled HIV infection.Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.Extrahepatic manifestations of hepatitis E virus.Atypical hemolytic uremic syndrome triggered by varicella infection.Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patientsExpertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serumThe French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France.Hepatitis E virus and neurologic disorders.Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infectionTreatment of chronic hepatitis C virus infection in dialysis patients: an updateNational sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.Ribavirin for chronic hepatitis E virus infection in transplant recipients.HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patientsNaive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt.Evaluation of a polymerase chain reaction-electrospray ionization time-of-flight mass spectrometry for the detection and subtyping of influenza viruses in respiratory specimens.An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European populationInterpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limitsConcordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism.Genotypic prediction of HIV-1 subtype D tropismAltered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
P50
Q26247138-868B52C2-E4B1-4856-9295-BD2974836C86Q26741395-4E825216-6E6F-41FA-9678-BB09198E2A87Q26996422-CB3EA28B-1CD0-4806-84C0-965CCBD29145Q27473035-69D54B99-562D-470A-9496-7D9D1F3C8708Q27473329-D26156B0-33EC-401C-A3FE-D4C05615AE4DQ27478380-6B4EB2B6-016C-4133-B58F-374B57533EABQ27484906-B9CDAD76-F03A-4FD9-8CCD-EB7F4BFAA714Q27928019-32838C92-F11D-43B4-8B02-7130263C99FCQ28476667-53C319E7-FB75-4D35-8EEB-A19B772A4AF7Q28478779-5FBA3320-3476-4514-9C4F-1ACD0EE8993EQ28552356-6508D363-C5C2-4326-A7FA-0D20E0DB65DFQ28956569-539A4AAC-3CBC-490A-89D1-79BE51DBCD30Q30051605-AE21ADFD-3593-43CF-8D84-70A02008AF3CQ30373928-BE8536E4-1952-40D3-B45D-28294885CBDEQ30486664-4B20620E-CF05-4D0D-A5AC-D882CCEEB6F4Q33374253-105E440E-2BFF-4A4E-A42C-ED5F9F7A5B86Q33417236-13DB9A91-F655-449C-A994-15136D03346BQ33430954-98549A3F-1593-45ED-AAE4-CA34E9E31A37Q33443814-0AA972DE-6913-4B5C-847F-3A38CB7B4D0FQ33558937-D2143D18-33E6-4F3C-AA65-B851EE38F6C9Q33712557-0C45A405-5735-4292-BD47-5AB6DDDCD950Q33726091-C8042766-5526-4C1B-85E8-75FED8DB9722Q33769950-726AD9BA-A089-4348-B794-DEE7AAC1F34EQ33825378-2C2520B2-775F-4F9E-8DFC-E17132226EF3Q34008923-1914CB4A-D915-4BFA-A4C7-C6EA39C3D83EQ34025611-12B813C7-E96D-497A-828A-4DC99E7F8987Q34045403-215E5505-1963-4A35-87C8-1CEF3E87E00DQ34190296-56474ECC-350B-4542-8AD5-77821875BFAEQ34340554-D7BB2E41-6C54-455E-A89D-259356268640Q34353387-AB10D172-8590-4524-B620-6C5C8F17D7FEQ34410881-F606EA09-57D4-485B-B66C-D8EC7D68072BQ34505231-5F64265E-8BE1-45ED-B18F-0A690D007F7DQ34569382-CE948ED0-E78D-4952-AD59-37104C4130EAQ34612510-193DA82B-1F31-416C-81E6-F792D6C4309BQ34655653-EADAD659-F539-4E4B-AEB5-96AE49789350Q34717939-B4CB214C-7865-48B5-A1DB-EED0AE4F7A85Q34741602-C6C3E991-54CB-47A7-B9F3-C4C350E03FE1Q35004817-CFBE6D31-80A4-44CC-BB3D-19FFB9EE872BQ35137552-A8AD3EA4-E3E8-45D4-92A6-44B981F82564Q35640599-77DCD3D5-F3DC-4D7F-8FFB-FF7935941D8F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jacques Izopet
@ast
Jacques Izopet
@en
Jacques Izopet
@es
Jacques Izopet
@nl
Jacques Izopet
@sl
type
label
Jacques Izopet
@ast
Jacques Izopet
@en
Jacques Izopet
@es
Jacques Izopet
@nl
Jacques Izopet
@sl
prefLabel
Jacques Izopet
@ast
Jacques Izopet
@en
Jacques Izopet
@es
Jacques Izopet
@nl
Jacques Izopet
@sl
P214
P106
P21
P214
P31
P735
P7859
viaf-173258670